2025 annual financial data
Marker Therapeutics 2025 Operating margin
Marker Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -363.45%.
Operating income was -12,890,426 USD and net income was -12,163,620 USD.
Operating cash flow was -12,014,081 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,546,669 USD
- Operating income
- -12,890,426 USD
- Net income
- -12,163,620 USD
- Operating cash flow
- -12,014,081 USD